Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Also known as Paracetamol (acetaminophen) solution experimental
Paracetamol experimental · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | - |
| 2 | PLACEBO_COMPARATOR | - |
| 3 | ACTIVE_COMPARATOR | - |
| Name | Type | Description |
|---|---|---|
| Paracetamol (acetaminophen) solution experimental | DRUG | 1 gm IV |
| paracetamol (acetaminophen) solution commercial | DRUG | 1 gm IV |
| placebo | DRUG | equivalent volume IV 0.9% sodium chloride (equivalent volume) |
Inclusion Criteria: * ASA I or II and scheduled for elective surgical extraction of 1 or more impacted mandibular 3rd molars, at least 1 of which must be a fully or partially impacted mandibular 3rd molar requiring mandibular bone removal. * Moderate or severe pain within 4 hours after the completi...
Paracetamol experimental is being studied for the treatment of postoperative pain. It is an investigational small molecule developed by Baxter International Inc. (BAX) and has completed a Phase 3 clinical trial in patients with post-surgical dental pain.
Paracetamol experimental is being developed by Baxter International Inc., which trades under the ticker symbol BAX. Baxter is a global medical products company, and this asset is part of its clinical pipeline for pain management.
Paracetamol experimental is in Phase 3 clinical development. One Phase 3 trial has been completed, and no active trials are currently listed. It is an investigational product and has not been approved by the FDA for any indication.
Paracetamol experimental has been evaluated in a single Phase 3 trial, NCT00406679, titled Analgesic Efficacy, Safety and Tolerability of Two Paracetamol-containing Solutions in Post-Surgical Dental Pain. The trial enrolled 135 participants in the United Kingdom and has been completed.
Yes, Paracetamol experimental is also known as Paracetamol (acetaminophen) solution experimental. Both names refer to the same investigational product developed by Baxter International Inc. for postoperative pain.